The European Food Safety Authority (EFSA) oversees the safety evaluation of genetically modified (GM) crops in the European Union. EFSA requires inclusion of commercial non-GM reference lines and a non-GM isoline in crop composition studies with GM crops. Reference lines are used to construct equivalence limits for each compositional analyte. Results for the GM line are compared with these equivalence limits to assess compositional equivalence between the GM crop and the non-GM crop. If compositional equivalence cannot be concluded from this comparison, then results for the non-GM isoline can be used to determine if this finding is likely the result of the background non-GM genetics of the GM crop. If this latter comparison is not sufficient to assess the compositional safety of the GM crop, then a biological-relevance assessment for the analytes in question can be completed taking into account the greater body of knowledge of composition for the crop and diets. Thus, the isoline is a useful comparator but not required to assess the compositional safety of the GM crop, and therefore, unavoidable genotype differences between the isoline and GM line should not be grounds for rejection of compositional studies where the biological relevance of potential non-equivalence is addressed.
Background on EFSA guidance
The European Food Safety Authority (EFSA) and the European Commission have prescriptive regulations governing the conduct, statistical analysis, and interpretation of crop composition studies that are completed to support the safety assessment of genetically modified (GM) crops (EFSA Panel on Genetically Modified Organisms (GMO), 2010; European Commission, 2013; van der Voet et al., 2011) . The concept of "substantial equivalence" is applied to crop composition studies; this concept recognizes that if the GM crop is compositionally equivalent to the corresponding non-GM crop, with the exception of the intended changes due to the expression of the GM traits, then the safety assessment can exclusively focus on intended changes (OECD, 1993) .
Crop composition studies are conducted to determine if the composition of the GM crop has been unexpectedly altered in a manner that could be adverse in the context of food and feed safety. EFSA requires that a minimum of six non-GM commercial reference lines (or hybrids) be included in each field study to generate equivalence limits for each compositional analyte. One can then determine if the mean values for the GM line fall within these in-study equivalence limits and if the confidence limits around the means for the GM line are contained within these in-study equivalence limits; based on these comparisons, different levels of confidence of compositional equivalence between the GM line and the non-GM crop can be assessed ("… there is more likely than not equivalence between the GMO and its reference" or "… GMO is equivalent to its reference", respectively). If equivalence cannot be confidently concluded from this comparison, then the biological relevance to safety is assessed (EFSA Panel on Genetically Modified Organisms (GMO), 2010). This may be based on the dietary exposure to the analyte in question (including the greater knowledge of crop composition beyond the current study) or comparison to the analyte concentration in the background non-GM genetics of the GM line. The latter comparison is possible via inclusion of an isoline, which is a non-GM line with background genetics close to those of the GM line. If the GM line and isoline have a similar analyte concentration and both differ from the equivalence limits of the reference lines, then it can be concluded that the compositional difference is attributable to the background non-GM genetics of the GM line and not to the GM traits or their insertion loci (see Fig. 1 ).
Here, we briefly discuss why isoline genetics are never perfectly matched with those of the GM line, how the comparison of the isoline and GM line are used to interpret compositional equivalence under EFSA guidelines, and why genotypic differences between the isoline and GM line are not critical to concluding compositional safety. We hope that this discussion will continue to focus the interpretation of these studies on the compositional safety of the GM crop by noting that a biological relevance assessment is an acceptable approach under EFSA guidance when equivalence cannot be concluded.
Isoline genetics
In addition to requiring compositional studies for new single GM events, EFSA also requires crop composition studies for breeding stacks (crosses) that are composed of previously approved GM single events. The production of an ideal isoline is technically challenging, especially for breeding stacks where the single component events were originally transformed into different genetic lines. This challenge is exacerbated by EFSA guidelines that do not allow null segregants from GM lines (lines derived from the GM line that do not have GM DNA) to be used as the isoline in crop composition studies (although null segregants may be included as an additional comparator). While one can match the average genetics of a cross between (or among) the parent lines to that 
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Regulatory Toxicology and Pharmacology 95 (2018) 204-206 of the GM cross used to produce the breeding stack, the distribution of genotypes in the two crosses will inevitably differ. Even after extensive backcrossing to an elite line, the GM line and the isoline will still differ in background genetics, especially for genes linked to the trait loci. This is exemplified by the ability to isolate different phenotypes from commercial elite lines (intravarietal variation) through single-plant selection and propagation (Fasoula and Boerma, 2007; Tokatlidis et al., 2008) . Similar to many traditionally bred lines, GM lines are derived from a single plant regenerated from a single cell in tissue culture. It is expected that a GM line, like any variety that has gone through this varietal development process, will have some compositional differences compared with the parent line if the experimental procedure has the power to detect small differences, as does the current study design (Herman and Price, 2013) . Thus, the GM line could be expected to have some statistical differences in analyte concentrations compared with the isoline but still be very similar to the isoline (Herman et al., 2017) , and also non-equivalent to the reference lines for some of the many compositional analytes assessed.
Use of isolines
Some confusion surrounding the purpose of the isolines in the compositional study seems to exist among risk assessors based on challenges to the genotype appropriateness of these isolines (personal observation). Specifically, regulators have questioned if the isoline and GM line are genetically close enough to make the study suitable for risk assessment. However, the more genetically distant the isoline is from the GM line, the more likely that the two lines will be found compositionally different, resulting in an insufficient explanation for nonequivalence between the GM line and the reference lines. This result may require a biological-relevance assessment for the analyte in question (incorporating the greater literature and knowledge of crop composition), but does not weaken the risk assessment. Thus, the presence of genetic differences between the isoline and GM line due to practical considerations does not scientifically justify automatic rejection of the study for safety assessment purposes.
Conclusions
Similar composition of the GM line to the isoline is sufficient to conclude negligible risk for analytes where compositional equivalence to the reference lines cannot be demonstrated, but this is not required to conclude safety. A biological-relevance assessment for analytes where equivalency to the reference lines or isoline cannot be demonstrated may also provide sufficient evidence of negligible risk. It should be recognized that: a) the background genotype for GM lines will never perfectly match that of the isoline, especially for breeding stacks, b) the compositional similarity between the GM lines and their isolines provides only one line of evidence to assess risk, and c) other lines of evidence, such as a biological-relevance assessment for the analytes in question, are sufficient to assess food and feed safety. As such, the rejection of composition studies due to the practical limitations of producing isolines that are genetically matched with GM lines is not scientifically justified.
